Sign in
Active, not recruitingNo phase

BAsel Syncope EvaLuation (BASEL IX) Study

Key facts

Who runs it
University Hospital, Basel, Switzerland
Where
Houston, United StatesSee the siteAlso in 8 other countries, 14 sites
Trial code
Status
Active, not recruiting
People taking part
3,500 people, planned
Started
Apr 2010
Ended
Dec 2025
Type of study
Observational
Record updated
15 April 2025

Who can take part

Age
40 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Patients presenting to the emergency department
  • Age > 40 years
  • Syncope within the last 12 hours
  • Written informed consent

Who cannot take part

  • Patients without loss of consciousness and with certain neurological causes (e.g. recurrent epilepsy, hemiplegia at presentation)
  • Age < 40 years
  • No written informed consent

Where in United States

Also in 8 other countries, 14 sites

  • Baylor College of MedicineHouston, United States

About the trial

What the trial wants to find out

Syncope is a major health problem. In the emergency department (ED), the management of patients with syncope still remains a clinical challenge because underlying diseases and prognosis can be extremely various. Structural heart disease and primary electrical disorders are major risk factors for sudden cardiac death and mortality in patients with syncope. In contrast, patients with reflex syncope and exclusion of structural heart disease have an excellent prognosis.

Read full original descriptionShow less

Therefore The investigators test the hypothesis that the use of a meticulous patient history, clinical examination and novel biomarkers can improve the rapid and accurate diagnosis of cardiac syncope in patients presenting to the ED and is able to improve risk stratification regarding adverse outcomes.

The prospective multicenter cohort study is designed to enroll 720 patients presenting with transient loss of consciousness within the last 12 hours to the ED. Blood samples for the measurement of novel biomarkers will be obtained at presentation.

All patients will be contacted by phone at 6, 12 and 24 months to determine major adverse events (death, resuscitation, recurrence of syncope, hospitalization for syncope).

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
15 April 2025